Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: Implications for the antitumor activity of interleukin 12 and/or interleukin 2

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1131-1136

  Wigginton, Jon M ^a   Kuhns, Douglas B ^b   Back, Timothy C ^a   Brunda, Michael J ^c   Wiltrout, Robert H ^a   Cox, George W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; EFFECTOR CELL; GROWTH INHIBITION; HELPER CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOKINE ACTIVATED KILLER CELL; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

ANIMALS; CELLS, CULTURED; INTERLEUKIN-12; INTERLEUKIN-2; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE;

EID: 0030056840     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Gazzinelli, R T., Hieny, S., Wynn, T. A., Wolf, S., and Sher, A. Interteukin-12 is required for the T-lymphocyte independent induction of interferon-γ by an intracellular parasite and induces resistance in T cell-deficient hosts. Proc. Natl. Acad Sci. USA, 90: 6115-6119, 1993.
2. Heinzel, H P., Schoenhaut, D. S., Revko, R. M., Rosser, L E , and Gately, M. K. Recombinant interleukin-12 cures mice infected with Leishmania major J. Exp. Med , 177: 1505-1509, 1993
3. Clemons, K. V., Brimmer, E., and Stevens, D. A. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother., 38: 460-464, 1994
4. Gazzinelli, R T , Grese, N A , and Morse, H. C In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med , 180: 2199-2208, 1994.
5. Nastala, C L., Edington, H D., McKinney, T. G , Tahara, H , Nalesnik, M. A., Brunda, M. J , Gately, M. K., Wolf, S. F , Schreiber, R D , Storkus, W. I., and Lotze, M T. Recombinant interleukin-12 administration induces tumor regression in association with IFN-γ production J. Immunol., 153: 1697-1706, 1994
6. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M K Antitumor and antimetastatic activity of interleukin-12 against murine tumors J. Exp Med., 178 1223-1230, 1993.
7. D'Andrea, A., Rengaraju, M., Valiante, N M., Chehimi, J., Kubin, M., Aste-Amezaga, M , Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E , Chizzonite, R., Wolf, S. F., and Trinchieri, G. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp. Med , 176: 1387-1398, 1992.
8. + NK cells. J. Immunol , 148: 2429-2436, 1992
9. Aste-Amezaga, M., D'Andrea, A., Kubin, M., and Trinchieri, G. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol , 156: 480-492, 1994
10. Kobayashi, M , Fitz, L., Ryan, W., Hewick, R. M., Clark, S. C , Chan, S., Loudon, R , Sherman, F , Perussia, B., and Trinchien, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp. Med , 170: 827-845, 1989.
11. Stern, A. S. Podlaski, F J , Hulmes, S D , Pan, Y E., Quinn, P. M , Wolitzky, A. G , Familletti, P C., Stremlo, D. L , Truitt, T , Chizzonite, R , and Gately, M K Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA, 87: 6808-6812, 1990.
12. Wolf, S. F., Temple, P A., Kobayashi, M., Young, D., Diclg, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R. M., Kelleher, K., Herrmann, S. H., Clark, S. C., Azzoni, L., Chan, S. H., Trinchien, G., and Perussia, B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol , 146: 3074-3081, 1991.
13. Gubler, U., Chua, A. O., Schoenhaut, D S., Dwyer, C. M , McComas, W., Motyka, R., Nabavi, N., Wolitzky, A. G., Quinn, P. M., Familletti, P. C., and Gately, M. K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA, 88: 4143-4147, 1991.
14. Schoenhaut, D. S., Chua, A. O., Wolitzky, A. G., Quinn, P. M., Dwyer, C M., McComas, W., Familletti, P. C., Gately, M. K., and Gubler, U. Cloning and expression of murine IL-12. J. Immunol., 148: 3433-3440, 1992.
15. Manetti, R., Parronchi, P., Gludizi, M. G , Piccinni, M P., Maggi, E., Trinchieri, G., and Romagnani, S. Natural killer cell stimulatory factor interleukin 12 (IL-12) induces T helper type 1 (Th1)-specific immune response and inhibits the development of EL-4-producing Th cells. J. Exp. Med., 177: 1199-1204, 1993.
16. Germann, T., Gately, M. K., Schoenhaut, D. S., Lohoff, M., Mattner, F., Fischer, S., Jin, S. C., Schmitt, E., and Rude, E. Interleukin-12/T cell stimulating factor: a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol , 23: 1826-1830, 1993
17. Marletta, M. A., Yoon, P. S., Lyengar, R., Leaf, C. D., and Wishnok, J. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry, 27: 8706-8711, 1988.
18. Stuehr, D. J., Kwon, N. S , Gross, S. S., Thiel, B. A., Levi, R., and Nathan, C. F. Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components. Biochem. Biophys. Res. Commun., 161: 420-426, 1989.
19. Nathan, C , and Xie, Q. Regulation and biosynthesis of nitric oxide J. Biol Chem., 269: 13725-13728, 1994.
20. Ding, A. H., Nathan, C. F , and Stuehr, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol., 141: 2407-2412, 1988.
21. Hibbs, J. B , Jr, Taintor, R. R., and Vavrin, Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science (Washington DC), 235: 473-476, 1987.
22. Stuehr, D. I., and Marletta, M. A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-γ. J. Immunol., 139: 518-525, 1987.
23. Cox, G. W., Melillo, G., Chattopadhyay, U., Mullet, D., Fertel, R. H., and Varesio, L. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-γ plus EL-2-induced murine macrophage tumoricidal activity. J. Immunol., 149: 3290-3296, 1992.
24. Drapier, J. C., Wietzerbin, J., and Hibbs, J. B., Jr. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J. Immunol., 18: 1587-1592, 1988.
25. Melillo, G., Cox, G. W., Biragyn, A., Sheffler, L A., and Varesio, L. Regulation of nitric-oxide synthase mRNA expression by interferon-γ and picolinic acid J Biol. Chem., 269: 8128-8133, 1994.
26. Cunha, F. Q., Assreuy, J., Moss, D. W., Rees, D., Leal, L. M. C., Moncada, S., Carrier, M., O'Donnell, C. A., and Liew, F. Y. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxinemia: role of TNF-α and IL-1-β. Immunology, 81: 211-215, 1994.
27. Hibbs, J. B., Jr., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R L., McMurry, M. P., Kushner, J P., and Samlowski, W. E Evidence for cytokine-inducible nitric oxide synthase from L-arginine in patients receiving interleukin-2 therapy. J. Clin Invest , 89: 867-877, 1992.
28. Melillo, G., Cox, G. W., Radzioch, D. and Varesio, L. Picolinic acid, a catabolite of L-Tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages J. Immunol., 150: 4031-4040, 1993.
29. Wang, M H , Cox, G W., Yoshimura, T., Sheffler, L. A., Steel, A., and Leonard, E. J. Macrophage-snmulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. J. Biol. Chem., 269: 14027-14031, 1994.
30. Weiss, G., Werner-Felmayer, G , Werner, E. R., Grunewald, K., Wachter, H., and Hentze, M. W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med., 180: 969-976, 1994.
31. Alleva, D. G., Burger, C. J., and Elgert, K. D Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production role of tumor-derived IL-10, TGF-β and prostaglandin. J. Immunol., 153: 1674-1686, 1994.
32. Calderòn, C. H., Huang, Z. H., Gage, D. A., Sotomayor, E. M., and Lopez, D. M. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J. Exp. Med., 180: 945-958, 1994
33. Huben, R. P., Connelly, R., Goldrose, M. H., Murphy, G. P., and Pomes, E J Immunotherapy of murine renal cancer. J. Urol., 129: 1075-1078, 1983
34. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K., and Mark, D. F. Biological activity of recombinant human interleukin 2 produced in Escherichia coli. Science (Washington DC), 223: 1412-1415, 1984.
35. Wang, A., Lu, S. D., and Mark, D. F. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science (Washington DC), 224: 1431-1433, 1984
36. Ding, A H., Nathan, C F., and Steuhr, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages comparison of activating cytokines and evidence for independent production. J. Immunol., 141: 2407-2412, 1988
37. Cox, G. W., Mathieson, B. J., Gandino, L., Blasi, E., Radzioch, D., and Varesio, L. Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl. Cancer Inst., 81: 1492-1496, 1989
38. Ochoa, J. B., Curti, B , Peitzman, A. B., Simmons, R. L., Billiar, T R., Hoffman, R., Rault, R., Longo, D L., Urba, W. J., and Ochoa, A C. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J. Natl. Cancer Inst., 84: 864-867, 1992.
39. Keller, R., Geiges, M., and Keist, R L-Arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res., 50: 1421-1425, 1990.
40. Liew, F. Y., Millott, S., Parkinson, C., Plamer, R. M., and Moncada, S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol., 144: 4794-4797, 1990.
41. Hibbs, J. R., Jr., Vavrin, Z., and Taintor, R R. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol., 138: 550-565, 1987.
42. Nathan, C. F., Brukner, L. H., Silverstein, S. C., and Cohn, Z. A. Extracellular cytolysis by activated macrophages and granulocytss I Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp. Med., 149: 84-99, 1979.
43. Adams, D O , Johnson, W. J., and Marino, P. A. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity. Fed. Proc., 41: 2212-2221, 1981
44. Adams, D. O., and Nathan, C. F Molecular mechanisms in tumor-cell killing by activated macrophages. Immunol. Today, 4: 166-170, 1983
45. Sotomayor, E. M., Fu, Y X., Lopez-Cepero, M., Herbert, L , Jiminez, J. J., Albarracin, C., and Lopez, D. M. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma II. Down-regulation of macrophage mediated cytotoxiaty by tumor-derived granulocyte-macrophage colony-stimulating factor. J. Immunol., 147: 2816-2823, 1991.
46. Sotomayor, E. M., Cheng, X. F., Fu, Y. X., Hawkins, A , Calderòn, C., and Lopez, D M. Impaired activation of tumoricidal function in macrophages from mammary tumor bearers: the role of IFN-γ. Int J. Oncol., 3: 719-728, 1993.
47. Sotomayor, E. M., DiNapoli, M R , Lopez-Cepero, N., and Lopez, D. M. The impaired tumoricidal function of macrophages from tumor bearing mice is related to defective nitric oxide production. J. Immunol., 150: 58a, 1993.
48. Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res., 54: 2462-2467, 1994.
49. Kwon, N. S , Stuehr, D. J., and Nathan, C. F Inhibition of tumor cell nbonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med., 174: 761-767, 1991.
50. Hibbs, J. B., Jr., Taintor, R R., Vavrin, Z., and Rachlin, E. M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun., 157: 87-94, 1988.
51. Drapier, J. C., Pellat, C., and Yann, H. Generation of EPR-detectable iron-nitrosyl complexes in tumor target cells cocultured with activated macrophages. J. Biol. Chem., 266: 10162-10167, 1991.
52. Xie, K., Huang, S., Dong, Z., Gutman, M , and Fidler, I. J. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362 Cancer Res., 55: 3123-3131, 1995
53. Xie, K., Huang, S., Dong, Z , Juang, S. H., Gutman, M., Zie, Q., Nathan, C., and Fidler, I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181: 1333-1343, 1995.
54. Lejeune, P., Lagadec, P , Onier, N., Pinard, D., Ohshima, H., and Jeannin, J F. Nitric oxide involvement in tumor-induced immunosuppression J Immunol., 152: 5077-5083, 1994.
55. Leibovich, S. J., Polverim, P. J., Fong, T. W., Harlow, L. A., and Koch, A. E. Production of angiogemc activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA, 91: 4190-4194, 1994
56. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl Acad. Sci. USA, 92: 4392-4396, 1995.
57. Buttery, L. D. K., Springall, D. R., Andrade, S P , Riveros-Moreno, V., Hart, J , Piper, P J., and Polak, J. M Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J. Pathol , 171: 311-319, 1993.
58. Kennovin, G. D., Hirst, D. G., and Flitney, F. W. Oral N-nitro-L-arginine methyl ester administration slows the growth of malignant tumours in rodents. Endothelium , 1: S52, 1993.
59. Wei, X., Charles, I. G., Smith, A , Ure, J , Feng, G., Huang, F., Xu, D., Muller, W., Moncada, S , and Liew, F Y Altered immune responses in mice lacking inducible nitric oxide synthaxe. Nature (Lond.), 375: 408-411, 1995.
60. Wigginton, J. M , Komschlies, K L., Back, T. C., Franco, J L , Brunda, M. J., and Wiltrout, R H. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst., 88: 38-43, 1996